STEROID-REFRACTORY PNEUMONITIS

Clinical trials for STEROID-REFRACTORY PNEUMONITIS explained in plain language.

Never miss a new study

Get alerted when new STEROID-REFRACTORY PNEUMONITIS trials appear

Sign up with your email to follow new studies for STEROID-REFRACTORY PNEUMONITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

New hope for cancer patients with dangerous drug side effect

Disease control Terminated

This study tested two drug combinations to treat severe lung inflammation (pneumonitis) in cancer patients. The inflammation was a serious side effect of certain cancer immunotherapies that didn't improve with standard steroid treatment. Researchers compared infliximab with intra…

Matched conditions: STEROID-REFRACTORY PNEUMONITIS

Phase: PHASE2 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control

Last updated Apr 02, 2026 14:57 UTC

STEROID-REFRACTORY PNEUMONITIS

Get alerted when new STEROID-REFRACTORY PNEUMONITIS trials appear

New hope for cancer patients with dangerous drug side effect